The H19-IGF2 imprinted gene region could be implicated in the risk of developing impaired renal function (IRF). Our aim was to determine the association of several common H19-IGF2 variants and IRF in a cohort of elderly healthy individuals. The study involved 675 individuals >65 years of age, 184 with type 2 diabetes mellitus (T2DM), and 105 with IRF (estimated glomerular filtration rate [eGFR] <60). They were genotyped for two common H19 single nucleotide polymorphisms (SNPs) (rs2839698 and rs10732516), one H19-IGF2 intergenic indel (rs201858505), and one indel in the 3′UTR of the IGF2. For the H19 SNPs, we also determined the allele present in the methylated chromosome through genotyping the DNA digested with a methylation-sensitive endonuclease. None of the four H19-IGF2 variants was associated with IRF in our cohort. We found a significantly higher frequency of the 3′UTR IGF2 deletion (D) in the eGFR <60 group (p = 0.01; odds ratio = 1.16, 95% confidence interval = 1.10–2.51). This association was independent of age and T2DM, two strong predictors of IRF. In conclusion, a common indel variant in the 3′UTR of the IGF2 gene was associated with the risk of IRF. This association could be explained by the role of IGF2 in podocyte survival, through regulation of IGF2 expression by differential binding of miRNAs to the indel sequences. Functional studies should be necessary to clarify this issue.
Get full access to this article
View all access options for this article.
References
1.
AzziS., Abi HabibW., and NetchineI. (2014). Beckwith-Wiedemann and Russell-Silver Syndromes: from new molecular insights to the comprehension of imprinting regulation. Curr Opin Endocrinol Diabetes Obes, 21, 30–38.
2.
BellJ.T., PaiA.A., PickrellJ.K., GaffneyD.J., Pique-RegiR., DegnerJ.F., et al. (2011). DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol, 12, R10.
3.
BergmanD., HaljeM., NordinM., and EngströmW. (2013). Insulin-like growth factor 2 in development and disease: a mini-review. Gerontology, 59, 240–249.
4.
BögerC.A., GorskiM., LiM., HoffmannM.M., HuangC., YangQ., et al. (2011). Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet, 7, e1002292.
5.
ChaoW., and D'AmoreP.A. (2008). IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev, 19, 111–120.
6.
CornuM., YangJ.Y., JaccardE., PoussinC., WidmannC., and ThorensB. (2009). Glucagonlike peptide-1 protects b cells against apoptosis by increasing the activity of an IGF-2/IGF1-receptor autocrine loop. Diabetes, 58, 1816–1825.
7.
CotoE., TaviraB, GómezJ., TrancheS., and CorteC.D. (2014). Effect of the FTO rs9930506 polymorphism on the main comorbidities of the cardiorenal metabolic syndrome in an elderly Spanish cohort. Cardiorenal Med, 4, 82.
8.
CowardR.J., WelshG.I., YangJ., TasmanC., LennonR., KoziellA., et al. (2005). The human glomerular podocyte is a novel target for insulin action. Diabetes, 54, 3095–3102.
9.
FloegeJ., HackmannB., KliemV., KrizW., AlpersC.E., JohnsonR.J., et al. (1997). Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int, 51, 230–243.
10.
GaboryA., JammesH., and DandoloL. (2010). The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays, 32, 473–480.
11.
GauntT.R., CooperJ.A., MillerG.J., DayI.N., and O'DellS.D. (2001). Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet, 10, 1491–1501.
12.
HaleL.J., WelshG.I., PerksC.M., HurcombeJ.A., and MooreS. (2013). Insulin-like growth factor-II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse. J Pathol, 230, 95–106.
13.
HarrisL.K., and WestwoodM. (2012). Biology and significance of signalling pathways activated by IGF-II. Growth Factors, 30, 1–12.
14.
Hernández-ValeroM.A., RotherJ., GorlovI., FrazierM., and GorlovaO. (2013). Interplay between polymorphisms and methylation in the H19/IGF2 gene region may contribute to obesity in Mexican-American children. J Dev Orig Health Dis, 4, 499–506.
15.
HurS.K., FreschiA., IderaabdullahF., ThorvaldsenJ.L., LuenseL.J., WellerA.H., et al. (2016). Humanized H19/Igf2 locus reveals diverged imprinting mechanism between mouse and human and reflects Silver-Russell syndrome phenotypes. Proc Natl Acad Sci U S A, 113, 10938–10943.
16.
KöttgenA., GlazeN.L., DehghanA., HwangS.J., KatzR., LiM., et al. (2009). Multiple novel loci are associated with indices of renal function and chronic kidney disease. Nat Genet, 41, 712–717.
17.
KöttgenA., PattaroC., BögerC.A., FuchsbergerC., OldenM., GlazerN.L., et al. (2010). Multiple New loci associated with kidney function and chronic kidney disease. Nat Genet, 42, 376–384.
18.
KulkarniR.N., BrüningJ.C., WinnayJ.N., PosticC., MagnusonM.A., and KahnC.R. (1999). Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell, 96, 329–339.
19.
LeveyA.S., BoschJ.P., LewisJ.B., GreeneT., RogersN., and RothD. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 130, 461.
20.
LiM., CareyJ., CristianoS., SusztakK., CoreshJ., BoerwinkleE., et al. (2017). Genome-wide association of copy number polymorphisms and kidney function. PLoS One, 12, e0170815.
21.
LiuM., RothA., YuM., MorrisR., BersaniF., RiveraM.N., et al. (2013). The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis. Genes Dev, 27, 2543–2548.
22.
LivingstoneC., and BoraiA. (2014). Insulin-like growth factor-II: its role in metabolic and endocrine disease. Clin Endocrinol (Oxf), 80, 773–781.
23.
LorenzenJ.M., and ThumT. (2016). Long noncoding RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol, 12, 360–373.
24.
MillerS.A., DykesD.D., and PoleskyH.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215.
25.
MaN., WangX., QiaoY., LiF., HuiY., ZouC., et al. (2011). Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner. Mol Cell Endocrinol, 333, 96–101.
26.
MeaburnE.L., SchalkwykL.C., and MillJ. (2010) Allele-specific methylation in the human genome: implications for genetic studies of complex disease. Epigenetics, 5, 578–582.
27.
ModiH., JacovettiC., TarussioD., MetrefS., MadsenO.D., ZhangF.P., et al. (2015). Autocrine action of IGF2 regulates adult β cell mass and function. Diabetes, 64, 4148–4157.
28.
MonnierP., MartinetC., PontisJ., StanchevaI., Ait-Si-AliS., and DandoloL. (2013). H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proc Natl Acad Sci U S A, 110, 20693–20698.
29.
NarayananR.P., FuB., PaytonA., HudsonJ.E., OliverR.L., AndersonS.G., et al. (2013). IGF2 gene polymorphisms and IGF-II concentration are determinants of longitudinal weight trends in type 2 diabetes. Exp Clin Endocrinol Diabetes, 121, 361–367.
30.
NgM.C., ShrinerD., ChenB.H., LiJ., ChenW.M., GuoX., et al. (2014). Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. PLoS Genet, 10, e1004517.
31.
NicaA.C., OngenH., IrmingerJ.C., BoscoD., BerneyT., AntonarakisS.E., et al. (2013). Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res, 23, 1554–1562.
32.
NordinM., BergmanD., HaljeM., EngströmW., and WardA. (2014). Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif, 47, 189–199.
33.
PagtalunanM.E., MillerP.L., Jumping-EagleS., NelsonR.G., MyersB.D., RennkeH.G., et al. (1997). Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest, 99, 342–348.
34.
PerkovicV., VerdonC., NinomiyaT., BarziF., CassA., PatelA., et al. (2008). The relationship between proteinuria and coronary risk: a systematic review and metaanalysis. PLoS Med, 5, e207.
35.
PidsleyR., DempsterE., TroakesC., Al-SarrajS., and MillJ. (2012). Epigenetic and genetic variation at the IGF2/H19 imprinting control region on 11p15.5 is associated with cerebellum weight. Epigenetics, 7, 155–163.
36.
PricciF., PuglieseG., RomanoG., RomeoG., LocuratoloN., PuglieseF., et al. (1996). Insulin-like growth factors I and II stimulate extracellular matrix production in human glomerular mesangial cells. Comparison with transforming growth factor. Endocrinology, 137, 879–885.
37.
RatajczakM.Z., ShinD.M., SchneiderG., RatajczakJ., and KuciaM. (2013). Parental imprinting regulates insulin-like growth factor signaling: a Rosetta Stone for understanding the biology of pluripotent stem cells, aging and cancerogenesis. Leukemia, 27, 773–779.
38.
RiobelloC., GómezJ., Gil-PeñaH., TrancheS., RegueroJ.R., de la HeraJ.M., et al. (2016). KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in the Spanish Renastur cohort. Mol Cell Endocrinol, 427, 86–91.
39.
SchultzB., YaoX., DengY., WanerM., SpockC., TomL., et al. (2015). A common polymorphism within the IGF2 imprinting control region is associated with parent of origin specific effects in infantile hemangiomas. PLoS One, 10, e0113168.
40.
SireeshaM., SambasivanV., KumarV.K., RadhaS., RajA.Y., and QurratulainH. (2009). Relevance of insulin-like growth factor 2 in the etiopathophysiology of diabetic nephropathy: possible roles of phosphatase and tensin homolog on chromosome 10 and secreted protein acidic and rich in cysteine as regulators of repair. J Diabetes, 1, 118–124.
41.
SoellnerL., BegemannM., MackayD.J., GrønskovK., TümerZ., MaherE.R., et al. (2017). Recent advances in imprinting disorders. Clin Genet, 91, 3–13.
42.
ThameemF., IgoR.P.Jr., FreedmanB.I., LangefeldC., HansonR.L., SchellingJ.R., et al. (2013). A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND). PLoS One, 8, e81888.
43.
WakelingE.L., BrioudeF., Lokulo-SodipeO., O'ConnellS.M., SalemJ., BliekJ., et al. (2017). Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol, 13, 105–124.
44.
WelshG.I., HaleL.J., EreminaV., JeanssonM., MaezawaY., LennonR., et al. (2010). Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab, 12, 329–340.
45.
YangC., TangR., MaX., WangY., LuoD., XuZ., et al. (2015). Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget, 6, 15311–15320.
46.
ZhouD., LiZ., YuD., WanL., ZhuY., LaiM., and ZhangD. (2015). Polymorphisms involving gain or loss of CpG sites are significantly enriched in trait-associated SNPs. Oncotarget, 6, 39995–40004.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
